Hot penny stocks... don't get burned
   

News for Xtl Biopharmaceutical (XTLB)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for XTL Biopharmaceuticals Ltd.  (XTLB) 
|
$ 1.9799      -0.6701 (-25.29%) Volume: 277.98 k 3:57 PM EDT Oct 10, 2008
Fri, Oct 10, 2008
2:00 PM Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2) - PR Newswire
Tue, Oct 07, 2008
7:35 AM XTL Biopharmaceuticals Announces Completion of the Bicifadine Phase 2b Study for Diabetic Neuropathic Pain - PR Newswire
Thu, Oct 02, 2008
11:37 AM XTL Biopharmaceuticals Extraordinary General Meetings Postponed Until October 10, 2008 - PR Newswire
Wed, Aug 27, 2008
6:23 PM Notification of Extraordinary General Meetings and Further Changes to Board Composition - PR Newswire
Fri, Aug 15, 2008
4:25 PM XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition - PR Newswire
Thu, Aug 14, 2008
4:05 PM XTL Biopharmaceuticals Announces Appointment of Samuel H. Rudman to Board of Directors - PR Newswire
7:35 AM XTL Biopharmaceuticals Announces First Half 2008 Financial Results - PR Newswire
Tue, Aug 05, 2008
7:35 AM XTL Biopharmaceuticals and Presidio Pharmaceuticals Amend License Agreement for Pre-Clinical Hepatitis C Program XTL to Receive Additional $2 Million in Cash in Return for a Reduction in Future Milestones and Royalties - PR Newswire
Sun, Jul 20, 2008
10:28 AM AGM / EGM Statements - PR Newswire
Thu, Jul 17, 2008
11:11 AM AGM / EGM Postponed to July 20, 2008 - PR Newswire
Tue, Jul 01, 2008
10:00 AM BeaconEquity.com Issues TraderNotes on Active Stocks: ORRV, XTLB, SHFL, CWSI, HRB, GVHR, TCHC, ORCL - PR Newswire
Mon, Jun 30, 2008
7:35 AM XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain - PR Newswire
Thu, Jun 12, 2008
12:46 PM Notification of Record Date for the Annual General Meeting and Extraordinary General Meeting - PR Newswire
8:59 AM Notification of Annual General Meeting and Extraordinary General Meeting and Jazz Pharmaceuticals Announces Development Timeline Updates - U.S. Equity News
Wed, Jun 11, 2008
5:50 PM Notification of Annual General Meeting and Extraordinary General Meeting - PR Newswire
Wed, May 28, 2008
7:35 AM XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors - PR Newswire
Thu, May 15, 2008
7:35 AM XTL Biopharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference - PR Newswire
Thu, Mar 20, 2008
5:15 PM XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007 - PR Newswire
9:01 AM Presidio Pharmaceuticals Obtains Exclusive Worldwide Rights to XTL Biopharmaceuticals Ltd. Hepatitis C Virus (HCV) NS5A Program - Business Wire
7:35 AM XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals - PR Newswire
Thu, Feb 07, 2008
7:35 AM XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference - PR Newswire
Mon, Jan 07, 2008
9:35 AM XTL Biopharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference - PR Newswire
7:30 AM XTL Biopharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference - PR Newswire
Mon, Dec 10, 2007
7:00 AM XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis - PR Newswire
Wed, Oct 31, 2007
7:43 AM XTL Announces Delisting From the Official List of the United Kingdom Listing Authority - PR Newswire
  Page 1 of 2   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for XTLB stock. Download XTLB report.
Research Report
Get the full report for FREE
Date:Sep 3, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download XTLB report
  
Example preview: Research report for Xtl Biopharmaceutical (XTLB) Research report for Xtl Biopharmaceutical (XTLB) Research report for Xtl Biopharmaceutical (XTLB) Research report for Xtl Biopharmaceutical (XTLB)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Xtl Biopharmaceutical
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.